NCT00799669 Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use Status UNKNOWN Phase N/A
NCT00798655 Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00791141 Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00790569 Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking Status COMPLETED Phase NA
NCT00790322 Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy Status COMPLETED Phase PHASE3
NCT00782691 Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas. Status UNKNOWN Phase N/A
NCT00779389 Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family Status COMPLETED Phase PHASE1
NCT00774319 TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck Cancer Status UNKNOWN Phase PHASE2
NCT00771641 Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE3
NCT00765440 Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract Status COMPLETED Phase PHASE3
NCT00765011 TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer Status COMPLETED Phase PHASE2
NCT00757549 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx Status COMPLETED Phase EARLY_PHASE1
NCT00756951 Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00756795 Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study) Status WITHDRAWN Phase NA
NCT00751816 Head & Neck Cancer Survivorship: Physical and Functional Status Status COMPLETED Phase N/A
NCT00750555 Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00738868 Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00738751 Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers Status COMPLETED Phase PHASE1